137 related articles for article (PubMed ID: 21220616)
21. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.
Tsujimura H; Miyaki T; Yamada S; Sugawara T; Ise M; Iwata S; Yonemoto T; Ikebe D; Itami M; Kumagai K
Int J Hematol; 2014 Nov; 100(5):507-10. PubMed ID: 25062797
[TBL] [Abstract][Full Text] [Related]
23. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
[TBL] [Abstract][Full Text] [Related]
24. Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery.
Oto M; Maeda A; Nose T; Ueda Y; Uneda S; Inadome A; Oshima K; Yoshida M
Intern Med; 2017 Oct; 56(20):2765-2768. PubMed ID: 28924109
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL.
Dalle JH; Leblond P; Decouvelaere A; Yakoub-Agha I; Preudhomme C; Nelken B; Mazingue F
Leukemia; 2003 Oct; 17(10):2056-7. PubMed ID: 14513060
[No Abstract] [Full Text] [Related]
26. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide therapy for aggressive histiocytic lesions in the pediatric population.
Bailey KM; Castle VP; Hummel JM; Piert M; Moyer J; McAllister-Lucas LM
J Pediatr Hematol Oncol; 2012 Aug; 34(6):480-3. PubMed ID: 22810753
[TBL] [Abstract][Full Text] [Related]
28. Primary retroperitoneal mucinous cystadenocarcinoma: a case report and review of the literature.
Dierickx I; Jacomen G; Schelfhout V; Moerman P; Corveleyn P; Spiessens T; Amant F; Berteloot P
Gynecol Obstet Invest; 2010; 70(3):186-91. PubMed ID: 20558993
[TBL] [Abstract][Full Text] [Related]
29. High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Clin Transplant; 2009; 23(6):839-47. PubMed ID: 20447186
[TBL] [Abstract][Full Text] [Related]
30. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
Kumar SK; Hayman SR; Kyle RA
Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
[TBL] [Abstract][Full Text] [Related]
31. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
32. [Retroperitoneal sarcoma: contribution to the repository CCAFU INCA.].
Avancès C; Rigaud J; Bui B; Camparo P; Culine S; Durand X; Sèbe P; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S290-6. PubMed ID: 21129647
[No Abstract] [Full Text] [Related]
33. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy.
Talamo G; Angtuaco E; Walker RC; Dong L; Miceli MH; Zangari M; Tricot G; Barlogie B; Anaissie E
J Clin Oncol; 2005 Aug; 23(22):5217-23. PubMed ID: 15955903
[TBL] [Abstract][Full Text] [Related]
34. First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M
Haematologica; 2004 Jul; 89(7):826-31. PubMed ID: 15257934
[TBL] [Abstract][Full Text] [Related]
35. Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma.
Kozuka T; Kiura K; Katayama H; Fujii N; Ishimaru F; Ikeda K; Ueoka H; Hamasaki S; Yoshino T; Kashihara Y; Date H; Tanimoto M; Harada M
Anticancer Res; 2002; 22(5):2939-44. PubMed ID: 12530021
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram.
Donahue TR; Kattan MW; Nelson SD; Tap WD; Eilber FR; Eilber FC
Cancer; 2010 Aug; 116(16):3883-91. PubMed ID: 20564145
[TBL] [Abstract][Full Text] [Related]
37. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
Hale GA
Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
[TBL] [Abstract][Full Text] [Related]
38. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
Ghobrial IM; Dispenzieri A; Bundy KL; Gastineau DA; Rajkumar SV; Therneau TM; Lacy MQ; Witzig TE; Litzow MR; Christensen BR; Hayman S; Pribula CG; Gertz MA
Bone Marrow Transplant; 2003 Sep; 32(6):587-92. PubMed ID: 12953131
[TBL] [Abstract][Full Text] [Related]
39. [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
Adam Z; Veselý K; Krejcí M; Pour L; Fakan F; Soumarová R; Neubauer J; Vanícek J; Cerný J; Kren L; Bolcák K; Smardová L; Hájek R; Mayer J
Vnitr Lek; 2009 Feb; 55(2):147-57. PubMed ID: 19348397
[TBL] [Abstract][Full Text] [Related]
40. Histiocytic sarcoma with two immunohistopathologically distinct populations.
Wakahashi K; Shimoyama M; Katayama Y; Minagawa K; Yoshida K; Sasaki R; Nakayama S; Yokozaki H; Yanagita E; Itoh T; Hayashi Y; Matsui T
Int J Hematol; 2010 Nov; 92(4):642-6. PubMed ID: 20924729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
